The use of cell kinetics in the development of drug combinations.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D002453:Cell Cycle; D002455:Cell Division / Q000187:drug effects*; D002469:Cell Separation; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000008:administration & dosage; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy; D008954:Models, Biological; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D003561:Cytarabine